000 | 01156 a2200325 4500 | ||
---|---|---|---|
005 | 20250513224710.0 | ||
264 | 0 | _c20001215 | |
008 | 200012s 0 0 eng d | ||
022 | _a1525-4135 | ||
024 | 7 |
_a10.1097/00042560-200010010-00018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLanzafame, M | |
245 | 0 | 0 |
_aDirectly observed therapy in HIV therapy: A realistic perspective? _h[electronic resource] |
260 |
_bJournal of acquired immune deficiency syndromes (1999) _cOct 2000 |
||
300 |
_a200-1 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aHIV _xisolation & purification |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTrevenzoli, M | |
700 | 1 | _aCattelan, A M | |
700 | 1 | _aRovere, P | |
700 | 1 | _aParrinello, A | |
773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 25 _gno. 2 _gp. 200-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042560-200010010-00018 _zAvailable from publisher's website |
999 |
_c11044419 _d11044419 |